Latest filing published 03 Mar 2026 for Pediatrix Medical Group, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mary Ann E. Moore (chief executive) discloses dealings in Pediatrix Medical Group, Inc. to SEC (Form 4). The record holds 17 filings, for trades running from 1 March 2022 to 1 March 2026.
On the market, this insider has only sold: 3 sales, €139k in total. Other entries cover 12 share grants.
The record was last updated on 3 March 2026 with a share grant (€453k) in Pediatrix Medical Group, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations